E.D.Cal.: DEA admin subpoena for prescription records enforced despite privacy interest

The DEA’s administrative subpoena for prescription records is enforced. While circuit law shows some privacy interest of persons named in the records, the DEA’s ability to get it overcomes that. United States v. Saxton, 2021 U.S. Dist. LEXIS 150296 (E.D.Cal. Aug. 10, 2021):

Regardless of whether Fourth Amendment rights can be asserted vicariously, Ninth Circuit case law appears to allow for giving consideration to the privacy rights of third parties in connection with the enforcement of administrative subpoenas. See United States v. Golden Valley Elec. Ass’n, 689 F.3d 1108, 1116 (9th Cir. 2012) (“Depending on the circumstances or the type of information, a company’s guarantee to its customers that it will safeguard the privacy of their records might suffice to justify resisting an administrative subpoena.”); U.S. E.E.O.C. v. McLane Co., 804 F.3d 1051, 1058 (9th Cir. 2015), vacated on other grounds and remanded sub nom. McLane Co. v. E.E.O.C., 137 S. Ct. 1159 (2017), as revised (Apr. 3, 2017) (weighing privacy of employee social security numbers in motion brought by the Equal Employment Opportunity Commission to enforce administrative subpoena in discrimination investigation); see also, In re Gimbel, 77 F.3d 593, 599 (2d Cir. 1996) (stating that “non-parties will generally be accorded more protection from sweeping administrative subpoenas”); In re McVane, 44 F.3d 1127, 1137 (2d Cir. 1995) (“Concern for [] privacy rights has at times caused this court to be more reluctant to enforce subpoenas when agencies have sought records of third parties who were not targets of the agency’s investigation.”). Thus, the Court cannot disregard the privacy rights of Respondent’s patients in deciding this motion.

That said, courts have consistently found that privacy rights involving medical and other personal records are outweighed by public interest in law enforcement, such as the DEA’s interest here in policing controlled substances. See, e.g., United States v. California, 2019 WL 2498318, at 1-2 (S.D. Cal. Mar. 26, 2019), reconsideration denied, 2019 WL 2498312 (S.D. Cal. May 9, 2019) (enforcing administrative subpoena for “sensitive patient information including the records of all prescriptions for controlled substances” in connection with “investigation into the possible diversion of fentanyl” under the federal Controlled Substances Act); Becker v. Kroll, 494 F.3d 904, 916-17 (10th Cir. 2007) (administrative subpoena for medical records of neurologist’s patients “not unreasonable under the Fourth Amendment” in investigation of Medicaid fraud); In re Subpoena Duces Tecum, 228 F.3d 341, 351 (4th Cir. 2000) (finding that government interest in “identifying illegal activity and in deterring future misconduct” outweighed “the privacy rights of those whose [medical] records were turned over to the government”); see also, Univ. of Pennsylvania v. E.E.O.C., 493 U.S. 182, 189-92 (1990) (denying protection to tenure-review materials for five faculty members in connection with discrimination investigation); Whalen v. Roe, 429 U.S. 589, 592-93, 600 (1977) (upholding state law collecting names and addresses of patients who received prescriptions for certain controlled substances); Williams v. Superior Ct., 3 Cal. 5th 531, 554-55 (2017) (stating that a “complete bans on disclosure to vindicate privacy interests … may significantly hamper the ability of aggrieved [*5] employees, deputized by the state, to assist in broad and effective enforcement of the labor laws”). The Court sees no material distinction between the records at issue here and the records at issue in cases finding that disclosure of third-party data was warranted, and thus, the Court will adopt the magistrate judge’s recommendation that the DEA’s petition to enforce administrative subpoena R9-19-179200 be granted.

This entry was posted in Subpoenas / Nat'l Security Letters. Bookmark the permalink.

Comments are closed.